Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-05-24 20:24:56
Reporting Period:
Accepted Time:
2018-05-24 20:24:56
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
939767 Exelixis Inc. EXEL Services-Commercial Physical & Biological Research (8731) 043257395
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202106 Lance Willsey C/o Exelixis, Inc.
210 E. Grand Ave.
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-05-22 50,000 $21.40 418,273 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Acquisiton 2018-05-24 31,167 $0.00 31,167 $20.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,167 2018-05-24 2025-05-23 No 4 A Direct
  1. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.26 to $21.60. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
  2. Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates.